Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report

INTRODUCTION: In this report, we describe the case of a patient with ocular chemical injury, symblepharon, and corneal neovascularization in whom subconjunctival injection of bevacizumab caused regression of corneal opacification and neovascularization, which led to visual improvement. CASE PRESENTA...

Descripción completa

Detalles Bibliográficos
Autores principales: Iannetti, Ludovico, Abbouda, Alessandro, Fabiani, Claudia, Zito, Roberta, Campanella, Michelangelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750591/
https://www.ncbi.nlm.nih.gov/pubmed/23889894
http://dx.doi.org/10.1186/1752-1947-7-199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750591/
https://www.ncbi.nlm.nih.gov/pubmed/23889894
http://dx.doi.org/10.1186/1752-1947-7-199

Ejemplares similares